TAB-021

antibody from Creative Biolabs

Targeting: IL1B IL-1B, IL1-BETA, IL1F2

ELISA (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Immunoprecipitation (Recommended by provider)

Immunohistochemistry (Recommended by provider)

Blocking/Neutralizing (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

TAB-021

Provider

Creative Biolabs

Product name

Anti-Human IL1Beta Therapeutic Antibody (Canakinumab)

Antibody type

Monoclonal

Description

Recombinant monoclonal antibody to Human IL1 beta. Canakinumab (INN, trade name Ilaris, previously ACZ885) is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.Canakinumab was for the treatment of rheumatoid arthritis. Canakinumab is as a possible treatment for chronic obstructive pulmonary disease, gout and coronary artery disease.

Reactivity

Human

Host

Human

Storage

Store at -20°C. Avoid multiple freeze/thaw cycles.